217 related articles for article (PubMed ID: 9209817)
1. Ergogenic drugs in sports.
Knopp WD; Wang TW; Bach BR
Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
[TBL] [Abstract][Full Text] [Related]
2. [Doping and urologic tumors].
Pinto F; Sacco E; Volpe A; Gardi M; Totaro A; Calarco A; Racioppi M; Gulino G; D'Addessi A; Bassi PF
Urologia; 2010; 77(2):92-9. PubMed ID: 20890867
[TBL] [Abstract][Full Text] [Related]
3. Sports pharmacology and ergogenic aids.
Ellender L; Linder MM
Prim Care; 2005 Mar; 32(1):277-92. PubMed ID: 15831323
[TBL] [Abstract][Full Text] [Related]
4. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
Fitch K
Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
[TBL] [Abstract][Full Text] [Related]
5. [Doping].
Kawahara T
Nihon Rinsho; 2000 Sep; 58 Suppl():162-6. PubMed ID: 11085108
[No Abstract] [Full Text] [Related]
6. Enhancement of athletic performance with drugs. An overview.
Wagner JC
Sports Med; 1991 Oct; 12(4):250-65. PubMed ID: 1686120
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular complications of doping products].
Demoulin R; Poyet R; Capilla E; Tortat AV; Pons F; Brocq FX; Druelle A; Jego C; Foucault G; Cellarier GR
Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):365-369. PubMed ID: 30290907
[TBL] [Abstract][Full Text] [Related]
8. [Doping: effectiveness, consequences, prevention].
Guezennec CY
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
[TBL] [Abstract][Full Text] [Related]
9. [The use of drugs to improve athletic performance].
Kuipers H; Hartgens F
Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
[TBL] [Abstract][Full Text] [Related]
10. Ergogenic aids.
Thein LA; Thein JM; Landry GL
Phys Ther; 1995 May; 75(5):426-39. PubMed ID: 7732086
[TBL] [Abstract][Full Text] [Related]
11. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
Sante; 2005; 15(3):167-70. PubMed ID: 16207578
[TBL] [Abstract][Full Text] [Related]
12. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
13. Performance-enhancing drugs, fair competition, and Olympic sport.
Catlin DH; Murray TH
JAMA; 1996 Jul; 276(3):231-7. PubMed ID: 8667569
[TBL] [Abstract][Full Text] [Related]
14. [Doping agents and their analytical control].
Szókán G
Acta Pharm Hung; 2002; 72(4):231-44. PubMed ID: 12812043
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
Thevis M; Schänzer W
Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
[TBL] [Abstract][Full Text] [Related]
16. Analytical strategy for detecting doping agents in hair.
Thieme D; Grosse J; Sachs H; Mueller RK
Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
[TBL] [Abstract][Full Text] [Related]
17. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
[TBL] [Abstract][Full Text] [Related]
18. [Sports and doping].
Yoshida T
Chudoku Kenkyu; 2003 Jul; 16(3):299-305. PubMed ID: 14582352
[No Abstract] [Full Text] [Related]
19. [Doping in sports].
Pirnay F
Rev Med Liege; 2001 Apr; 56(4):265-8. PubMed ID: 11421166
[TBL] [Abstract][Full Text] [Related]
20. Nutritional supplements and ergogenic AIDS.
Liddle DG; Connor DJ
Prim Care; 2013 Jun; 40(2):487-505. PubMed ID: 23668655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
